Indian pharmaceutical companies Biophore and its subsidiary Zenara Pharma in Hyderabad get approval from the CDSCO for manufacturing and marketing of neuro disorder drug.
Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to severe cases of COVID-19.